Search - tctmd.com

Displaying 681 - 700 of 1588

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Presentation TCT 2019

The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial

Presenter: Mark Reisman

September 27, 2019

Presentation TCT 2019

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

PFO Closure for Primary Prevention: The Debate Has Started — A Case Example and a Clinical Trial Proposal

Presenter: Fabian Nietlispach

September 27, 2019

Presentation TCT 2019

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

Insights into the PRECISE Randomized Clinical Trial

Presenter: Sreekanth Vemulapalli

September 26, 2019

Presentation TCT 2019

Case Presentation, Evolving Technology, and Clinical Trial Status

Presenter: Torsten Vahl

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

Experience on the Early Feasibility Study (US Industry’s View)

Presenter: Robert Thatcher

September 26, 2019

Presentation TCT 2019

Making the Case for… - Surgical Perspectives: Not So Fast, We Need a Randomized Trial!

Presenter: Patrick McCarthy

September 26, 2019

Presentation TCT 2019

Making the Case for… - Case Presentation, Rationale, and UNLOAD Trial Updates

Presenter: Nicolas van Mieghem

September 26, 2019

Presentation TCT 2019

Making the Case for… - Rationale and Trial Updates

Presenter: Philippe Genereux

September 26, 2019

Presentation TCT 2019

Making the Case for… - Clinical Trial Updates, Anatomic Considerations, and Optimizing Procedural Outcomes

Presenter: Raj Makkar

September 26, 2019

Presentation TCT 2019

Experience on the Global Clinical Trial (Japanese Industry’s View)

Presenter: Daiki Yasuhara

September 26, 2019

Presentation TCT 2019

The Basic Regulation Pathway For an Early Feasibility Study in the US

Presenter: Hiren Mistry

September 26, 2019

Presentation TCT 2019

The Basic Regulation Pathway For a Clinical Trial in Japan Compared to US Regulation

Presenter: Mitsuru Yuba

September 26, 2019

Presentation TCT 2019

FDA Pivotal Clinical Trial Design and Beyond

Presenter: Ori Ben-Yehuda

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

Advertisement

TCT 2019 Day Two: Transcatheter Valves, New and Old

The Antiplatelet Drug Test to Determine Responsivity and the Next-Generation PFO Closure Migraine Trial

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

PFO Closure for Primary Prevention: The Debate Has Started — A Case Example and a Clinical Trial Proposal

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Insights into the PRECISE Randomized Clinical Trial

Case Presentation, Evolving Technology, and Clinical Trial Status

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Experience on the Early Feasibility Study (US Industry’s View)

Making the Case for… - Surgical Perspectives: Not So Fast, We Need a Randomized Trial!

Making the Case for… - Case Presentation, Rationale, and UNLOAD Trial Updates

Making the Case for… - Rationale and Trial Updates

Making the Case for… - Clinical Trial Updates, Anatomic Considerations, and Optimizing Procedural Outcomes

Experience on the Global Clinical Trial (Japanese Industry’s View)

The Basic Regulation Pathway For an Early Feasibility Study in the US

The Basic Regulation Pathway For a Clinical Trial in Japan Compared to US Regulation

FDA Pivotal Clinical Trial Design and Beyond

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content